| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000013235 |
| Receipt No. | R000015379 |
| Official scientific title of the study | An exploratory study of the efficacy and safety of yokukansan for postoperative delirium in patients who underwent surgical resection of malignant tumor of digestive system. |
| Date of disclosure of the study information | 2014/02/26 |
| Last modified on | 2018/09/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | An exploratory study of the efficacy and safety of yokukansan for postoperative delirium in patients who underwent surgical resection of malignant tumor of digestive system. | |
| Title of the study (Brief title) | A clinical study of yokukansan in patients with postoperative delirium after surgical resection of malignant tumor of digestive system. | |
| Region |
|
|
| Condition | ||
| Condition | Digestive system cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the inhibition effect and safety of yokukansan for onset of postoperative delirium in elderly. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of postoperative delirium |
| Key secondary outcomes | Postoperative length of stay in the hospital
Severity of symptoms of delirium Safety |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | yokukansan administering group(7.5mg/day) | |
| Interventions/Control_2 | yokukansan non-administering group (0mg/day) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients who scheduled surgical resection of malignant tumor of digestive system.
2) Patients who can be administered drugs orally. 3) Patients who give written informed consent to participate in the study |
|||
| Key exclusion criteria | 1) Patients who require emergency surgery.
2)Patients with severe complications, including cardiac, renal, blood or lung diseases, or with other complications judged to be life-threatening. 3)Patients administered antipsychotic agents and therapeutic agents for dementia. 4)Patients administered Kampo medicines other than the study drug. 5) Patients who were judged to be inappropriate as subjects by the study investigators |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Tsunehiko Maruyama |
| Organization | Hitachi,Ltd.,Hitachi General Hospital |
| Division name | Surgery |
| Address | 2-1-1,Jonann-cho,Hitachi-si,Ibaraki-Ken,Japan |
| TEL | 0294-23-1111 |
| tsunehiko.maruyama.kq@hitachi.com | |
| Public contact | |
| Name of contact person | Masayo Okawa |
| Organization | Hitachi,Ltd.,Hitachi General Hospital |
| Division name | clinical research center |
| Address | 2-1-1,Jonann-cho,Hitachi-si,Ibaraki-Ken,Japan |
| TEL | 0294-23-1111 |
| Homepage URL | |
| masayo.okawa.ne@hitachi.com | |
| Sponsor | |
| Institute | Hitachi,Ltd.,Hitachi General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 株式会社日立製作所 日立総合病院(茨城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015379 |